Description
Roger Pharma INSULYX (IGF-1 LR3) is a peptide formulation containing Insulin-Like Growth Factor-1 Long R3 (IGF-1 LR3), a modified analogue of IGF-1 that is widely studied for its prolonged biological activity and interaction with cellular growth, muscle regeneration, and tissue repair pathways. Due to its extended half-life, IGF-1 LR3 is commonly researched in studies involving muscle cell development, recovery, and metabolic function.
Each pack contains 5 vials, with 125 mcg of IGF-1 LR3 per vial, providing a total peptide content of 625 mcg. Roger Pharma INSULYX is supplied in a lyophilized format and is intended for research applications involving peptide science, regenerative biology, and growth factor studies.
Key Features
- IGF-1 LR3 peptide formulation
- 125 mcg per vial
- 5 vials per pack
- Total peptide content: 625 mcg
- Lyophilized peptide format
- Studied for muscle regeneration and cellular growth pathways
- Research-focused peptide compound
Contents
- Active Ingredient: Insulin-Like Growth Factor-1 Long R3 (IGF-1 LR3) – 125 mcg
- Quantity: 5 Vials
Reviews
There are no reviews yet.